Paid Clinical Trials in New Orleans, LA
As of September 2026, 400 paid clinical trials are recruiting in New Orleans, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
New Orleans offers studies at sites including University Medical Center New Orleans for conditions such as Atrial Fibrillation, Malignant Solid Neoplasm, Hypertension, Anatomic Stage II Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in New Orleans
Trials by drug in New Orleans
Filter results
Newly added in New Orleans
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Detection of Atrial Fibrillation Using PPG From Smartphone Cameras
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
367 clinical trials
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Study of DONQ52 in Active Celiac Disease
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Top Research Study Locations in New Orleans
Researchers run research studies in New Orleans, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University Medical Center New Orleans | Anatomic Stage II Breast Cancer AJCC v8, Heart Failure, Malignant Solid Neoplasm | 48 |
| Ochsner Medical Center Jefferson | Advanced Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia | 46 |
| Ochsner Clinic Foundation | Neoplasm Metastasis, Acute Stroke, Chronic Low-back Pain | 33 |
| Children's Hospital New Orleans | Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 28 |
| Louisiana State University Health Science Center | Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Anatomic Stage I Breast Cancer AJCC v8 | 17 |
| Tulane University | Ulcerative Colitis, Aneurysm, Brain, Anxiety | 17 |
| DelRicht Research | Chronic Pain, Osteoarthritis, Knee, Acute Gout Flare | 12 |
| Ochsner Medical Center | Aortic Valve Disease, Aortic Valve Stenosis, Hypertension | 10 |
| Tulane University School of Medicine | Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2 | 10 |
| University Medical Center | Atrial Fibrillation, Hidradenitis Suppurativa, Abdominal Wound Dehiscence | 10 |
| Touro Infirmary | Anatomic Stage II Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 9 |
| Louisiana State University Health Sciences Center | Aortoiliac Occlusive Disease, Breast Cancer, Dacryocystitis | 8 |
| Louisiana State University | Aortic Stenosis, Calcific, Aortic Valve Stenosis, Articular Fractures | 7 |
| East Jefferson General Hospital | Atrial Fibrillation, Atrial Arrhythmia, Atrial Flutter | 6 |
| Ochsner Baptist Medical Center | Abdominal Wound Dehiscence, Anal Fistula, Endometrial Carcinoma | 6 |
| Ochsner Health | Advanced Solid Tumor, Age-related Macular Degeneration (AMD), Coronary Arterial Disease (CAD) | 6 |
| Tulane University Medical Center | Acute Kidney Injury, Covid19, Diffuse Cutaneous Systemic Sclerosis | 6 |
| Ochsner Health System | Cardiovascular Diseases, Degenerative Disc Disease, Eustachian Tube Dysfunction | 4 |
| University Medical Center - New Orleans | Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | 4 |
| Southeast Louisiana Veterans Health Care System, New Orleans, LA | Secure Firearm Storage, Suicidal Ideation, Suicide | 3 |
| Tulane Cancer Center | Bladder Carcinoma, Colon Adenocarcinoma, Cutaneous Melanoma | 3 |
| Tulane Doctors - Speciality Care - Napoleon | Atrial Fibrillation, Cardiomyopathies, Obstructive Sleep Apnea | 3 |
| Tulane Medical Center | Community-acquired Pneumonia, Influenza, COVID-19, Interstitial Lung Disease, Kidney Transplant Rejection | 3 |
| DelRicht Research - LCMC Health Urgent Care - Lakeview | Gout, Tophaceous Gout | 2 |
| LSU Health New Orleans | Cervical Cancer, Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer | 2 |
Active & Upcoming Studies in New Orleans (2026)
Recruiting trials in New Orleans grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (113 active studies)
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer · Phase 1 · TerSera Therapeutics LLC
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (40 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- The RESPLASH Study · Tulane University
Neurology & pain (32 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (11 active studies)
- Periodontal Inflammation and Epigenetics in Obese Individuals · Louisiana State University Health Sciences Center in New Orleans
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
HIV / STI (10 active studies)
- Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program · Xavier University of Louisiana.
- Combatting HIV Or Other STIs Early (CHOOSE) · Phase 2 · Westat
Mental health & behavior (9 active studies)
- Brexanolone Lifting Outcomes Of Moms · Phase 3 · Lipocine Inc.
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
Vaccines (4 active studies)
- A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose · Phase 3 · Pfizer
- Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · University of Illinois at Urbana-Champaign
Eye & vision (3 active studies)
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients · Phase 4 · Tulane University
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
Pediatric (3 active studies)
- Multicenter HomeVENT: Home Values and Experiences Navigation Track · Johns Hopkins University
- Supportive Hospital-Based Intervention for Firearm Trauma · Tulane University
Common conditions studied in New Orleans
- Atrial Fibrillation (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Hypertension (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Breast Cancer (5 active studies)
- Cardiovascular Diseases (5 active studies)
Leading research sponsors in New Orleans
- National Cancer Institute (NCI)
- Tulane University
- Children's Oncology Group
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in New Orleans?
There are approximately 400 recruiting clinical trials in New Orleans, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New Orleans pay participants?
Most recruiting trials in New Orleans compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New Orleans?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New Orleans?
The most common conditions under active study in New Orleans include Atrial Fibrillation (7), Malignant Solid Neoplasm (7), Hypertension (6), Anatomic Stage II Breast Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New Orleans?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Orleans on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New Orleans?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New Orleans?
Recruiting research sites in New Orleans include University Medical Center New Orleans, Ochsner Medical Center Jefferson, Ochsner Clinic Foundation, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New Orleans right now?
The largest active categories in New Orleans are Cancer & tumors (113), Cardiovascular (40), Neurology & pain (32). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.